Operating profit before deduction of amortization: igmbio.com (IGMS)
The lack of regular revenue for the biotech startup is confirmed by the EBITDA growth trajectory, where the indicator value stands at . The financial stability of IGM Biosciences, Inc. (IGMS) is based on R&D successes, remaining independent of economic cycles. The project's capitalization relies on its partnership with Sanofi and strict compliance with FDA regulatory requirements in the development of immunotherapeutic agents.
IGM Biosciences (IGMS) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio IGM Biosciences, Inc.|IGMS - Long-Term Debt to Capital|Current Liabilities to Capital IGM Biosciences Inc.|IGMS - Company Aggregate Debts|Debts to Net Assets IGM Biosciences|IGMS - Company Long-Term Debts|Short-Term Indebtedness IGM Biosciences|Quick Liquidity Indicator igmbio.com
- earnings and multiples data:
IGMS - Net Income|Expected Net Income IGM Biosciences, Inc.|IGMS - P/E Multiple|Future Price to Earnings IGM Biosciences Inc.|IGMS - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio IGM Biosciences|IGMS - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months IGM Biosciences|IGMS - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months igmbio.com|IGMS - Earnings growth in current year|Expected earnings per share growth for next year IGM Biosciences, Inc.
Summary company analytics:IGMS IGM Biosciences, Inc.
For the long-term investor, the reliability of IGM Biosciences, Inc. (IGMS) is determined by its ability to monetize its scientific authority in the field of targeted antibodies. By analyzing the cash operating profit before deductions, we assess the net cash flow from the core business excluding taxes and interest, which this chart confirms as the company's financial viability during a period of expensive capital.
Who IGM Biosciences, Inc. competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|Operating income before deduction of amortization Vera Corp VERA|DNTH: Operating profit EBITDA|Operating profit before depreciation charges pharvaris.com PHVS|Profit before payment of interest, taxes and amortization AbCellera Biologics Inc.|Operating profit before deduction of amortization Tourmaline Bio Inc (TRML)|Operating profit before deduction of amortization PGEN (Intrexon)|PHAR (Pharming Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (Nektar Therapeutics)|upstreambio.com - Profit before payment of interest, taxes and amortization|Zenas Biopharma - Operating profit EBITDA|Operating income before deduction of amortization Immunome Inc IMNM|Gossamer Corp (GOSS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization KalVista Corp (KALV)|Profit before payment of interest, taxes and amortization Septerna Inc|pieris.com (PVLA) - Operating income before deduction of amortization|Operating profit EBITDA SVRA|Operating profit before deduction of amortization Rigel Pharma RIGL|Operating profit EBITDA ANAB (AnaptysBio Corp)|Operating income before deduction of amortization Astria Corp (ATXS)|enGene Holdings Inc. - Operating profit EBITDA|Profit before interest, taxes and amortization RAPT Therapeutics Inc.|aerovatetx.com (JBIO) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ACRS|KYTX (Kyverna) - Operating profit EBITDA|Operating profit before deduction of amortization Tiziana Life Sciences, Ltd. (TLSA)|Operating profit EBITDA CABA|VTYX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Theratechnologies THTX|Operating income before deduction of amortization Avalo Therapeutics, Inc. (AVTX)|ELDN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AGEN (Agenus, Inc)|CLYM: Operating profit EBITDA|ZURA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization aTyr Pharma|Operating profit before amortization ADAG (Adagene Corp)|Operating profit EBITDA IMA|Operating profit before deduction of amortization shattucklabs.com STTK|Equillium - Operating profit before deduction of amortization|Operating income before deduction of amortization Connect Biopharma Holdings (CNTB)|Immunic Inc - Operating profit EBITDA|Operating income before deduction of amortization Atara Biotherapeutics ATRA|IFRX: Operating profit EBITDA|Operating profit before depreciation charges X4 Pharmaceuticals, Inc XFOR|Profit before payment of interest, taxes and amortization Adicet Bio Inc.|Operating profit before deduction of amortization Celularity Corp (CELU)|Profit before payment of interest, taxes and amortization INmune Bio (INMB)|Operating income before deduction of amortization Barinthus Biotherapeutics PLC|Profit before payment of interest, taxes and amortization Kezar Life Sciences, Inc KZR|SABS (SAB Biotherapeutics Inc) - Profit before deduction of interest, taxes, depreciation and amortization|Akari Therapeutics - Operating profit EBITDA|Income before deduction of interest, taxes and amortization ENLV (Enlivex Therapeutics)|QTTB: Operating profit EBITDA|GeoVax Labs (GOVX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Edesa|IBIO: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Carisma Therapeutics (CARM)|Operating profit before deduction of amortization xtlbio.com XTLB|Operating profit EBITDA BOLT (Bolt Biotherapeutics, Inc.)|Operating profit EBITDA HCW Biologics, Inc. HCWB|APVO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AIM (AIM ImmunoTech, Inc.)|ADTX: Operating profit EBITDA|GRI - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization XORTX Therapeutics|Operating profit before deduction of amortization Vyome Holdings Inc. (HIND)|Profit before payment of interest, taxes and amortization Revelation Bio (REVB)|Operating profit before deduction of amortization Indaptus Corp INDP|Scinai Immunotherapeutics - Operating profit before deduction of amortization|Operating profit EBITDA CalciMedica Inc CALI|AFMD - Profit before payment of interest, taxes and amortization|ALLK (Allakos Inc.) - Operating profit before amortization|HOOK: Operating profit EBITDA|Profit before interest, taxes and amortization iTeos Pharma (ITOS)|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|tcbiopharm.com (TCBP) - Operating income before deduction of amortization|Operating profit EBITDA THRD
